SCHEMBL6201965

SCHEMBL6201965

CCOC(=O)c1cnc(C(=O)CBr)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
CYP1A2 P05177 1/20 0.47
LMNA P02545 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
GABRA1 P14867 7/20 0.46
GABRG2 P18507 7/20 0.46
GABRB3 P28472 7/20 0.46
GABRA5 P31644 7/20 0.46
GABRA3 P34903 7/20 0.46
GABRA2 P47869 7/20 0.46
GABRA4 P48169 7/20 0.46
GABRA6 Q16445 7/20 0.46
GABRP O00591 6/20 0.46
GABRD O14764 6/20 0.46
GABRB1 P18505 6/20 0.46
GABRB2 P47870 6/20 0.46
GABRE P78334 6/20 0.46
GABRG1 Q8N1C3 6/20 0.46
GABRG3 Q99928 6/20 0.46
GABRQ Q9UN88 6/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1019601 0.87 CYP1A2 (0.59) POLBCYP1A2LMNAL3MBTL1GABRA1
SCHEMBL1644358 0.81 POLB (0.46) POLBCYP1A2LMNAL3MBTL1GABRA1
SCHEMBL8883054 0.81 POLB (0.49) POLBCYP1A2LMNAL3MBTL1GABRA1
SCHEMBL1644521 0.80 POLB (0.70) POLBCYP1A2LMNAL3MBTL1RXFP1
SCHEMBL1644378 0.80 CYP1A2 (0.52) POLBCYP1A2LMNAL3MBTL1GABRA1
SCHEMBL6202564 0.80 CYP1A2 (0.53) POLBCYP1A2GABRA1GABRG2GABRB3
SCHEMBL27594663 0.79 LMNA (0.44) POLBCYP1A2LMNAL3MBTL1GABRA1
SCHEMBL197360 0.79 CYP1A2 (0.50) POLBCYP1A2LMNAL3MBTL1GABRA1
SCHEMBL15751480 0.78 POLB (0.49) POLBCYP1A2LMNAL3MBTL1RXFP1
SCHEMBL7999648 0.77 SIRT6 (0.52) POLBCYP1A2LMNAL3MBTL1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 EP disclosed
US-RE37556-E1 (ALKOXYPHENYL)THIAZOLE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed
US-5677319-A THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-10-14 US disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
US-5639770-A SUPEROXIDE INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-06-17 US disclosed
EP-0600092-A1 THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-06-08 EP disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 EP disclosed